Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ICON plc

< Previous 1 2 3 Next >
ICON Reports Second Quarter 2024 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON announces results of Annual General Meeting and changes to the Board of Directors
From ICON plc
Via Business Wire
Tickers ICLR
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Second Quarter 2024 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the Jefferies Global Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to hold Investor Day Meeting on May 30, 2024
From ICON plc
Via Business Wire
Tickers ICLR
ICON releases its ICON Cares 2023 Report
From ICON plc
Via Business Wire
Tickers ICLR
ICON Announces Pricing of USD 2 Billion Notes
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports First Quarter 2024 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON Announces CFO Transition
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules First Quarter 2024 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at Upcoming Investor Conferences
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Fourth Quarter and Full Year 2023 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
From ICON plc
Via Business Wire
Tickers ICLR
ICON Issues Financial Guidance for Full Year 2024
From ICON plc
Via Business Wire
Tickers ICLR
Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023
From ICON plc
Via Business Wire
Tickers ICLR
ICON Secures Upgraded Credit Rating from Moody’s Investors Service
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at Upcoming Investor Conferences
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Third Quarter 2023 Results
From ICON plc
Via Business Wire
Tickers ICLR
ICON Secures Upgraded Credit Rating from S&P Global Ratings
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc Schedules Third Quarter 2023 Earnings Conference Call
From ICON plc
Via Business Wire
Tickers ICLR
ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
From ICON plc
Via Business Wire
Tickers ICLR
BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
From ICON plc
Via Business Wire
Tickers ICLR
ICON plc to Present at the Baird Global Healthcare Conference
From ICON plc
Via Business Wire
Tickers ICLR
ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
From ICON plc
Via Business Wire
Tickers ICLR
ICON Reports Second Quarter 2023 Results
From ICON plc
Via Business Wire
Tickers ICLR
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.